Trials / Completed
CompletedNCT00254189
Study Evaluating Effects of Levonorgestrel and Ethinyl Estradiol on Ovulation
A Single Center, Open-Label Study to Evaluate the Effects on Ovulation of Levonorgestrel 90mg and Ethinyl Estradiol 20mg in a Daily, Continuous, Oral Regimen.
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 60 (planned)
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer · Industry
- Sex
- Female
- Age
- 0 Years – 36 Years
- Healthy volunteers
- Accepted
Summary
To determine the ability of a monophasic oral contraceptives ("OC") regimen of Levonorgestrel ("LNG") 90 mg and Ethinyl Estradiol ("EE") 20 mg to inhibit ovulation during 84 days of continuous therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Levonorgestrel | |
| DRUG | Ethinyl Estradiol |
Timeline
- Start date
- 2002-12-01
- Completion
- 2004-10-01
- First posted
- 2005-11-15
- Last updated
- 2006-05-19
Source: ClinicalTrials.gov record NCT00254189. Inclusion in this directory is not an endorsement.